Weight loss, activity, and nutrition can lower progression risk from prediabetes to type 2 diabetes.
分類彙整: 減肥減重
Weight Loss Surgery: When Medication Is Not Enough
Metabolic and bariatric surgery can be appropriate for some patients and requires lifelong follow-up.
Naltrexone/Bupropion: Appetite, Cravings, and Safety Screening
This medicine may help some patients but requires screening for blood pressure, seizures, mood, and drug interactions.
Orlistat: A Non-GLP-1 Medication for Weight Management
Orlistat reduces fat absorption and requires attention to dietary fat, vitamins, and gastrointestinal effects.
Oral Semaglutide and Weight: Understanding Its Role
Oral semaglutide is used mainly in diabetes care and should be taken exactly as prescribed.
Telehealth Weight Loss Programs: What Safe Care Should Include
Safe telehealth care includes medical screening, medication review, follow-up, nutrition guidance, and emergency instructions.
Compounded or Online GLP-1 Products: Safety Concerns
Unapproved or unclear-source products may carry risks related to ingredients, dosing, sterility, and oversight.
Switching Weight Loss Medicines: Questions to Ask Your Clinician
Medication changes should consider response, side effects, cost, availability, contraindications, and health goals.
What If Semaglutide or Tirzepatide Does Not Work as Expected?
Response varies, and clinicians may reassess adherence, dose tolerance, nutrition, activity, sleep, and other conditions.
Long-Term Treatment: Why Stopping Medication May Lead to Regain
Because obesity is chronic, stopping effective treatment can allow appetite and weight regain to return.
